Electromedical Technologies, Inc Quarterly Return On Equity in % from Q4 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Electromedical Technologies, Inc quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q2 2024.
  • Electromedical Technologies, Inc Return On Equity for the quarter ending June 30, 2024 was 42.7 %, a 79.1% decline year-over-year.
  • Electromedical Technologies, Inc annual Return On Equity for 2023 was 121 %, a 39% decline from 2022.
  • Electromedical Technologies, Inc annual Return On Equity for 2022 was 199 %, a 65.9% decline from 2021.
  • Electromedical Technologies, Inc annual Return On Equity for 2021 was 585 %, a 161% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 42.7 -161 -79.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 106 -70 -39.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 121 -77.7 -39% Oct 1, 2023 Dec 31, 2023
Q3 2023 155 -173 -52.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 204 -287 -58.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 176 -317 -64.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 199 -385 -65.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 328 -113 -25.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 491 +56.6 +13% Apr 1, 2022 Jun 30, 2022
Q1 2022 494 +118 +31.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 585 +361 +161% Oct 1, 2021 Dec 31, 2021
Q3 2021 440 +236 +116% Jul 1, 2021 Sep 30, 2021
Q2 2021 434 +348 +405% Apr 1, 2021 Jun 30, 2021
Q1 2021 376 +316 +528% Jan 1, 2021 Mar 31, 2021
Q4 2020 224 +147 +189% Oct 1, 2020 Dec 31, 2020
Q3 2020 204 Jul 1, 2020 Sep 30, 2020
Q2 2020 85.9 Apr 1, 2020 Jun 30, 2020
Q1 2020 59.8 Jan 1, 2020 Mar 31, 2020
Q4 2019 77.4 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.